About the Product

Description


Sildodime S Tablet containing Silodosin and Solifenacin is used for the management of benign prostatic hyperplasia (BPH) and overactive bladder symptoms. It helps in improving urinary flow and reducing urinary frequency and urgency.

Silodosin works by relaxing smooth muscles in the prostate and bladder neck to improve urine flow, while Solifenacin helps reduce bladder muscle overactivity and improves bladder control.

The tablet is widely prescribed in urology practice for long-term management of urinary symptoms, leading to consistent demand and repeat usage.

With increasing prevalence of urinary disorders in aging populations, this product offers strong business potential for retailers and distributors. Its long-term therapy requirement, steady prescription demand, and growing acceptance make it a reliable product for consistent sales and growth in the urology segment.

Some patients may experience dizziness, dry mouth, constipation, blurred vision, or ejaculation disorders. Rarely, urinary retention or severe allergic reactions may occur and require medical attention.

Sildodime S Tablet is indicated for the management of benign prostatic hyperplasia (BPH) with associated symptoms such as frequent urination, urgency, nocturia, and weak urine flow. It helps improve bladder control, reduce urinary frequency, and enhance urinary comfort.

This medicine should be used under medical supervision. Caution is advised in patients with kidney or liver disorders. It may cause dizziness, so care should be taken while driving or operating machinery.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Sildodime S Tablet in the PCD pharma franchise market?

Sildodime S Tablet, containing Silodosin 8mg and Solifenacin 5mg, has strong demand in the urology segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners focusing on urinary disorders and prostate care portfolios.

Why should medical distributors include Sildodime S Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for medicines used in benign prostatic hyperplasia (BPH), urinary urgency, frequency, and overactive bladder symptoms. Sildodime S Tablet helps strengthen a comprehensive urology product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Sildodime S Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Sildodime S Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Sildodime S Tablet distribution?

Wholesalers and medical agencies benefit from strong urology prescription demand, steady sales potential, reliable product availability, and professional support when partnering for Sildodime S Tablet distribution.

How can I become a distributor or franchise partner for Sildodime S Tablet?

Medical distributors, stockists, and wholesalers interested in Sildodime S Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.